Connect with us

Hi, what are you looking for?

Stock

U.S. expected to purchase 10 million courses of Pfizer COVID-19 pill – WaPo

Stock Markets28 minutes ago (Nov 16, 2021 02:00PM ET)

(C) Reuters. FILE PHOTO: A 3D printed Pfizer logo is placed near medicines from the same manufacturer in this illustration taken September 29, 2021. REUTERS/Dado Ruvic/Illustration

(Reuters) -U.S. President Joe Biden’s administration is expected to announce this week the purchase of 10 million courses of Pfizer Inc (NYSE:PFE)’s experimental COVID-19 pill, the Washington Post reported on Tuesday https://www.washingtonpost.com/health/2021/11/16/administration-purchases-pfizer-anti-covid-pill, citing people familiar with the matter.

Earlier this month, Pfizer, which also makes one of the mostly widely used COVID-19 vaccines, said the pill https://reut.rs/3oxaxnz cut the chance of hospitalization or death for adults at risk of severe disease by 89% in its clinical trial.

Pfizer expects to submit interim trial results for the pill, branded Paxlovid, to the Food and Drug Administration (FDA) before the Nov. 25 U.S. Thanksgiving holiday.

The pill will compete with Merck & Co Inc’s similar oral drug, molnupiravir, which was shown to halve the chances of dying or hospitalization for COVID-19 patients at high risk of serious illness. Merck applied for U.S. emergency use authorization for its drug in October and has already received regulatory clearance in Britain.

The price struck between the administration and Pfizer for its drug is less than that for the Merck pill, closer to $500 per treatment, the report said, adding that the final details have not been chalked out.

Pfizer did not immediately respond to a Reuters request for comment.

U.S. expected to purchase 10 million courses of Pfizer COVID-19 pill – WaPo

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

World News

Insomnia is the most common sleep disorder in the global population. Therefore, it is a problem that many people suffer or have suffered...

World News

George Soros and Bill Gates are part of a consortium acquiring a British developer of rapid-testing technology, including for Covid-19 and tropical diseases,...

Tech

If you parked your car in one of the thousands of parking spots across Calgary, there’s a good chance you paid the Calgary Parking...

Investing

ForexMay 27, 2021 02:04AM ET (C) Reuters. By Peter Nurse Investing.com — The dollar edged higher in early European trade Thursday, finding support from...

Disclaimer: Yourmorningvoice.com it's managers and its employees (collectively "The Company") do not make any guarantee or warranty about what is advertised or above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. Copyright © 2021 Your Morning Voice. All Rights Reserved